-
Vertex Pharmaceuticals Earnings Preview: Analysts Expect Falling Revenue, Rising EPS Over Last Quarter
Monday, July 25, 2011 - 1:49pm | 582Vertex Pharmaceuticals (NASDAQ: VRTX) releases its next round of earnings this Thursday, July 28, 2011. Here's Benzinga's essential guide to Vertex Pharmaceuticals' second quarter earnings report. Earnings and Revenue: Analysts are bracing for a loss of 92 cents per share and revenues of $52....
-
Monday's Put/Call Ratio Leaders
Monday, July 25, 2011 - 12:15pm | 76Here are today's Put/Call Ratio leaders… 1. Regeneron Pharmaceuticals (NASDAQ: REGN) 5,759 puts, 52 calls 2. Cemex (NYSE: CX) 7,697 puts, 199 calls 3. Saks Inc. (NYSE: SKS) 5,156 puts, 291 calls 4. McKesson Corp. (NYSE: MCK) 4,386 puts, 254 calls 5. Trina Solar (NYSE: TSL) 4,890 puts, 359 calls
-
NASDAQ Stocks Hitting 52-Week Lows
Monday, July 25, 2011 - 10:20am | 126TOP Ships Inc (NASDAQ: TOPS) shares lost 11.76% to create a new 52-week low of $2.68. TOPS' 52-week trading range is $0.35-$2.98. RRSat Global Communications Network Ltd (NASDAQ: RRST) shares fell 5.00% to touch a new 52-week low of $5.70. RRST shares have dropped 29.82% over the past 52 weeks,...
-
Winners as of 10:15AM
Monday, July 25, 2011 - 10:19am | 80Idenix Pharma (NASDAQ: IDIX) is trading up over 8% after being rated Overweight at JP Morgan. CNH Global (NYSE: CNH) is trading up over 7% after releasing earnings. Brunswick Corp (NYSE: BC) is trading up roughly 6%. Helca Mining (NYSE: HL) is trading up over 3% after gold reached new nominal...
-
NASDAQ Stocks Hitting 52-Week Highs
Monday, July 25, 2011 - 10:14am | 131Virtus Investment Partners Inc (NASDAQ: VRTS) shares jumped 0.97% to create a new 52-week high of $79.04. VRTS shares have jumped 229.32% over the past 52 weeks, while the S&P 500 index has gained 21.98% in the same period. Transcat Inc (NASDAQ: TRNS) shares gained 6.95% to touch a new 52-week...
-
Biogen Idec Receives Conditional Approval in the European Union for FAMPYRA® to Improve Walking in Adults with Multiple Sclerosis
Monday, July 25, 2011 - 9:13am | 311Biogen Idec (NASDAQ: BIIB) announced today it has received conditional approval from the European Commission for FAMPYRA® (prolonged-release fampridine tablets) to improve walking in adult patients with multiple sclerosis (MS) who have walking disability (Expanded Disability Status Scale 4-7)....
-
Threshold Pharmaceuticals Announces Initiation of Clinical Trial Evaluating TH-302 in Combination with Bevacizumab at University of Texas at San Antonio
Monday, July 25, 2011 - 9:05am | 313Threshold Pharmaceuticals, Inc. (Nasdaq: THLD), today announced that the University of Texas at San Antonio initiated a clinical trial of TH-302 in combination with bevacizumab in patients with recurrent high grade astrocytoma including glioblastoma. Bevacizumab, marketed by Roche under the brand...
-
The Lancet Publishes Clinical Trial Data That Demonstrate Statistically Significant and Dose-Dependent Expression of Dystrophin in Duchenne Muscular Dystrophy Patients Treated With AVI BioPharma's Eteplirsen
Monday, July 25, 2011 - 7:07am | 79AVI BioPharma, Inc. (NASDAQ: AVII) today announced that data published in The Lancet from a Phase 1b/2 study of eteplirsen, the Company's exon-skipping therapy for the treatment of Duchenne muscular dystrophy, demonstrate that the treatment was well tolerated and was shown to induce statistically...
-
Earnings Expectations for the Week of July 25
Sunday, July 24, 2011 - 9:40am | 1439The earnings crunch continues this week even as the month of July winds to a close. Quarterly reports of note scheduled for the week include those from Netflix (NASDAQ: NFLX), United Parcel Service (NYSE: UPS), Exxon Mobil (NYSE: XOM), Starbucks (NASDAQ: SBUX), Merck (NYSE: MRK) and Dow Chemical (...
-
Stock Watchlist For Next Week
Friday, July 22, 2011 - 6:29pm | 2279( click to enlarge ) BioSante Pharmaceuticals, Inc. (NASDAQ:BPAX) is forming a symmetrical triangle with support at $3.53. I am expecting a breakout at $3.79. So far, all indicators are in favor of an upward price movement: all the 3 major moving averages are below the current price and MACD...
-
Arena Pharmaceuticals Trades to Two Month High
Friday, July 22, 2011 - 3:10pm | 136Shares of Arena Pharmaceuticals (NASDAQ: ARNA) are trading higher on the session by 5.03%, at $1.56. The stock just rallied through this month's high, at $1.53, and has its eyes set on the 200-day moving average, at $1.80. The stock is now trading at a two month high, though traders see more...
-
Thursday's Top Performing Small Cap Stocks (SFN, ATX, CTIC, SCHL, ASGN)
Friday, July 22, 2011 - 2:16pm | 356The weekly jobless claims rose again and remained above 400,000, which is not a good sign. But that didn't stop Dutch staffing giant Randstad from offering $771 million for SFN Group (NYSE: SFN), an American competitor. The deal will double Randstad's U.S. presence. SFN's stock led all small caps...
-
Thursday's Top Performing Small Cap Stocks (SFN, ATX, CTIC, SCHL, ASGN)
Friday, July 22, 2011 - 2:16pm | 356The weekly jobless claims rose again and remained above 400,000, which is not a good sign. But that didn't stop Dutch staffing giant Randstad from offering $771 million for SFN Group (NYSE: SFN), an American competitor. The deal will double Randstad's U.S. presence. SFN's stock led all small caps...
-
Options Brief: Exact Sciences
Friday, July 22, 2011 - 1:02pm | 86Shares of Exact Sciences (NASDAQ: EXAS) are higher on the session by 3.72%, trading at $9.19. Overall call volume is now running at 3.60x the daily average, with 82% of all calls traded being purchases on the offer. 1,507 contracts have traded on the session so far. Exact Sciences Corporation is...
-
Biotech/Pharma Trading News Alert for BioSante
Friday, July 22, 2011 - 12:39pm | 1028Point Roberts, WA, LINCOLNSHIRE, Ill - July 22, 2011 - Investorideas.com, a leader in sector stock research for independent investors , issues a trading alert for specialty biotech/pharma stock, BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) for July 22 nd . The stock traded as high as $3.73 on July...